Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Landau Jeffrey B
Chief Business Officer at CytomX Therapeutics. Filing since 20 Jul 2022.
CIK 0001918615
Company
Date
Role
Action
Shares
Amount
Of holding
CTMX
CytomX Therapeutics, Inc.
20 Aug 2024
Chief Business Officer
Sold at will
4,181
$5.14K
3.4%
CTMX
CytomX Therapeutics, Inc.
19 Mar 2024
Chief Business Officer
Sold at will
6,562
$13.69K
5.6%
CTMX
CytomX Therapeutics, Inc.
20 Dec 2023
Chief Business Officer
Sold at will
4,077
$5.63K
4.5%
CTMX
CytomX Therapeutics, Inc.
22 Sep 2023
Chief Business Officer
Sold at will
4,119
$5.36K
5.1%
CTMX
CytomX Therapeutics, Inc.
16 Mar 2023
Chief Financial Officer
Sold at will
1,477
$2.92K
2.1%
CTMX
CytomX Therapeutics, Inc.
20 Jul 2022
Chief Business Officer
Sold, plan not stated
4,206
$5.98K
12.0%
6 decisions on file.
